Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1952;5:534-538

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SAMPSON, J. J.
Right arrow Articles by SOLOMON, B. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SAMPSON, J. J.
Right arrow Articles by SOLOMON, B. C.

(Circulation. 1952;5:534.)
© 1952 American Heart Association, Inc.


Studies of Plasma Quinidine Content

III. The Value of Delayed Absorptive Coated Tablets in Oral Quinidine Therapy

JOHN J. SAMPSON M.D.1; HARRY FOREMAN M.D.1; BERTRAM C. SOLOMON M.D.1

1 From the Department of Medicine and The Harold Brunn Institute for Cardiovascular Research, Mount Zion Hospital, San Francisco, Calif.

Quinidine sulfate, orally administered in tablets coated with a material delaying their absorption, produces concentration curves in the blood serum similar to those of uncoated tablets. However, there is a delay in the appearance and the attaining of maximum concentrations with the coated tablets, although higher levels may persist for 12 hours. Defects in coating may cause faulty failure of absorption. The advantages of using such a preparation of quinidine are: (1) avoidance of nausea in susceptible persons, (2) providing effective concentrations of the drug during the night and thereby preventing nocturnal attacks of arrhythmias, and (3) providing greater concentrations of the drug in the morning, when attempts at conversions of arrhythmias may require therapy over several days or more.




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
N. Shaftel and A. Halpern
The Quinidine Problem
Angiology, February 1, 1958; 9(1): 34 - 46.
[PDF]


Home page
Arch Intern MedHome page
S. BELLET, D. FINKELSTEIN, and H. GILMORE
Study of a Long-Acting Quinidine Preparation: Experience in Normal Subjects and in Patients with Myocardial Abnormality
Arch Intern Med, November 1, 1957; 100(5): 750 - 758.
[Abstract] [PDF]